Conception rates and calving intervals after prostaglandin F2 alpha or prebreeding progesterone in dairy cows

Two experiments were performed in two different herds to determine if utilizing prostaglandin F 2 alpha to induce estrus for first services would be effective in reducing the duration and variability of calving intervals. In Experiment 1, cows were assigned randomly as controls (n = 217) to be inseminated as they were detected in estrus (beginning d 42 to 53 postpartum depending on replicate) or treated with prostaglandin F2 alpha (n = 185). In Experiment 2, the same treatments were utilized, except control cows (n = 124) were inseminated at their first detected estrus after d 40 postpartum, and treated cows received either one injection of prostaglandin F2 alpha between d 54 and 63 (n = 116) or were given progesterone (via a progesterone-releasing intravaginal device) for 7 d, with the device removed 24 h after prostaglandin F2 alpha (n = 116). More cows were inseminated and pregnancy rates were higher within 5 d after treatment with prostaglandin F2 alpha, and interval from prostaglandin F2 alpha to first service was reduced compared with that of control cows. Duration and variation of calving intervals were unaffected in either experiment, despite the fact the elective waiting period was 6 to 23 d longer for treated cows than for controls. Prebreeding treatment with progesterone failed to improve conception rates, but the efficiency of estrous expression increased from 54% in prostaglandin F2 alpha-treated cows to 71% in those cows also receiving prebreeding progesterone. We conclude that prostaglandin F2 alpha was ineffective in improving reproductive performance of these herds under good herd management. However, prostaglandin F2 alpha offers the convenience of inseminating small groups of cows, controlling when breedings occur during the work week, and prolonging the elective waiting period without extending the calving interval.     

Fertility of postpartum dairy cows after administration of gonadotropin-releasing hormone and prostaglandin F2 alpha: a field trial

Our objective was to examine further the potential profertility effects of gonadotropin-releasing hormone and prostaglandin F2 alpha in postpartum Holstein cows. Reproductive performance was monitored in 843 cows milked thrice daily. One group of cows (n = 218) was untreated, while three groups received either 100 micrograms gonadotropin-releasing hormone administered once between d 11 and 25 (n = 211); 25 mg prostaglandin F2 alpha given once between d 11 and 25 (n = 215); or 25 mg prostaglandin F2 alpha given once between d 25 and 40 postpartum (n = 190). No profertility effects were detected in cows, regardless of their health status during the periparturient period, except cows given gonadotropin-releasing hormone between d 11 and 18 had shorter intervals to first estrus and to first service than controls. Cows with reproductive disorders (abnormal health status) in the concurrent lactation had longer intervals from calving to conception after receiving gonadotropin-releasing hormone between d 18 and 25 or prostaglandin F2 alpha between d 33 and 40. Abnormal health status adversely affected every reproductive trait measured. Early postpartum treatments with either hormone failed to improve reproductive performance of dairy cows, in contrast to several reports of profertility effects for gonadotropin-releasing hormone, and a few reports for prostaglandin F2 alpha.     

Controlling first service and calving interval by prostaglandin F2 alpha, gonadotropin-releasing hormone, and timed insemination

Our objective was to determine if calving intervals could be shortened and made less variable by using prostaglandin F2 alpha to control the occurrence of first services. Holstein cows (n = 348) were assigned at calving to four treatment groups. Control cows (n = 88) were inseminated at their first observed estrus after 40 d postpartum. Estrous cycles of the remaining cows were synchronized with prostaglandin F2 alpha to allow insemination (first services) 80 h after the second injection (n = 86), insemination at 80 h preceded by gonadotropin-releasing hormone at 72 h (n = 86), or insemination at 72 and 96 h (n = 88) after the second injection (51 to 57 d postpartum). By design, interval to first service was reduced to 57 d for treated cows (63 d for controls) and was less variable (12% of that for controls). Conception rate at first service was lower after timed inseminations than that of controls. Intervals to conception and subsequent calving were similar in all treated cows and controls. Of cows sampled, 23 of 176 (13%) failed to respond with luteolysis when progesterone in serum exceeded 1 ng/ml, and 26 of 176 (15%) had low concentrations of progesterone in serum and could not respond to prostaglandin F2 alpha. Poor response to timed inseminations may have occurred because only 72% of 176 cows sampled responded with luteolysis. When only cows observed in estrus were considered, conception rate approached that of controls (51%).(ABSTRACT TRUNCATED AT 250 WORDS)     

Estrus synchronization of lactating dairy cows with GnRH, progesterone, and prostaglandin F2 alpha

The reproductive performance of synchronized cows was compared with that of nonsynchronized cows. In trial 1, cyclic cows in five seasonal herds were randomly divided into two groups. Cows in one group (n = 515) were treated with a GnRH agonist and an intravaginal progesterone device, followed in 7 d by a PGF2 alpha injection, and the device was removed 1 d after PGF2 alpha. Cows in the other group (n = 512) did not receive any treatment and acted as control. In trial 2, the treatments were similar to those used in trial 1 except that the progesterone device was removed at the time of PGF2 alpha injection (synchronized: n = 516; control: n = 512). The estrus synchronization rate was 92.8% in trial 1 and 92.2% in trial 2. Conception rate to first artificial insemination (AI) was lower for synchronized cows than for control cows in trial 1 (56.5 vs. 62.7%), but similar in trial 2 (64.6 vs. 63.3%). Across both trials, the pregnancy rate during the AI breeding period was greater for the synchronized cows (85.6%) than for the control cows (81.2%). The synchronization treatment reduced the interval from start of the breeding season to conception for cows conceiving by AI (8.9 vs. 14.8 d) or by AI or natural mating (14.1 vs. 21.6 d). The synchronization protocol used in trial 2 achieved better conception rate than that used in trial 1, but the precision of estrus was less in trial 2 than in trial 1.     

Targeted reproductive management for lactating Holstein cows: Reducing the reliance on exogenous reproductive hormones

Adoption of automated monitoring devices (AMD) affords the opportunity to tailor reproductive management according to the cow's needs. We hypothesized that a targeted reproductive management (TRM) would reduce the use of reproductive hormones while increasing the percentage of cows pregnant 305 d in milk (DIM). Holstein cows from 2 herds (n = 1,930) were fitted with an AMD at 251.0 ± 0.4 d of gestation. Early-postpartum estrus characteristics (EPEC; intense estrus = heat index ≥70; 0 = minimum, 100 = maximum) of multiparous cows were evaluated at 40 (herd 1) or 41 (herd 2) DIM and EPEC of primiparous cows were evaluated at 54 (herd 1) or 55 (herd 2) DIM. Control cows received the first artificial insemination at fixed time (TAI; primiparous, herd 1 = 82 and herd 2 = 83 DIM; multiparous, herd 1 = 68 and herd 2 = 69 DIM) following the Double-Ovsynch (DOV) protocol. Cows enrolled in the TRM treatment were managed as follows: (1) cows with at least one intense estrus were inseminated upon AMD detected estrus for 42 d and, if not inseminated, were enrolled in the DOV protocol; and (2) cows without an intense estrus were enrolled in the DOV protocol at the same time as cows in the control treatment. Control cows were re-inseminated based on visual or patch aided detection of estrus, whereas TRM cows were re-inseminated as described for control cows with the aid of the AMD. Cows received a GnRH injection 27 ± 3 d after insemination and, if diagnosed as nonpregnant, completed the 5-d Cosynch protocol and received TAI 35 ± 3 d after insemination. Among cows in the TRM treatment, 55.8 and 42.9% of primiparous and multiparous cows, respectively, received the first insemination in spontaneous estrus. The interaction between treatment and parity affected pregnancy 67 d after the first AI (primiparous: control = 37.6%, TRM = 27.4%; multiparous: control = 41.0%, TRM = 44.7%). The TRM treatment increased re-insemination in estrus (control = 48.3%, TRM = 70.5%). Pregnancy 67 d after re-inseminations tended to be affected by the interaction between treatment and EPEC (no intense estrus: control = 25.3%, TRM = 32.0%; intense estrus: control = 32.9%, TRM = 32.2%). The interaction between treatment and EPEC affected pregnancy by 305 DIM (no intense estrus: control = 80.8%, TRM = 88.2%; intense estrus: control = 87.1%, TRM = 86.1%). Treatment did not affect the number of reproductive hormone treatments among cows that had not had an intense estrus (control = 10.5 ± 0.3, TRM = 9.1 ± 0.2 treatments/cow), but cows in the TRM treatment that had an intense estrus received fewer reproductive hormone treatments than cows in the control treatment (2.0 ± 0.1 vs. 9.6 ± 0.2 treatments/cow). Selecting multiparous cows for first AI in estrus based on EPEC reduced the use of reproductive hormones without impairing the likelihood of pregnancy to first AI. The use of AMD for re-insemination expedited the establishment of pregnancy among cows that did not display an intense estrus early postpartum.     

Synchronization of estrus in dairy cows with prostaglandin F2 alpha and estradiol benzoate

A field study using 322 lactating dairy cows in seven commercial and two university herds was conducted to determine if treatment with estradiol benzoate 40 to 48 h after treatment with prostaglandin F2 alpha would enhance synchronization of estrus. Estrogen treatment tended to increase the proportion of cows in estrus within 5 d (synchronized) after prostaglandin treatment (66.9% versus 58.9%). Of synchronized cows, a greater proportion treated with estrogen (66.9%) were in estrus on d 3 than those not receiving estrogen (48.2%). First service conception rate (31.9%) and interval to second service (35.6 d) were not affected by treatment with estrogen. Milk progesterone was measured in university herds. More cows with milk progesterone concentrations greater than or equal to 8 ng/ml were synchronized (75.4%) than those with less than 8 ng/ml (63.3%). Treatment with estrogen increased synchrony of cows with high progesterone (90.3%) more than prostaglandin alone (60.0%). Based on progesterone concentrations at breeding and 22 to 24 d later, estimated conception rate was 58.7%, and net conception rate based on palpation was 41.3%. Tighter synchrony of estrus can be achieved by using estradiol benzoate 40 to 48 h after prostaglandin. Concentrations of milk progesterone might predict success of treatment.     

Evaluation of reproductive performance in lactating dairy cows with prostaglandin F2alpha, gonadotropin-releasing hormone, and timed artificial insemination

Nine hundred and twenty Holstein cows from 16 commercial dairy herds to evaluate three systematic breeding protocols: 14-d PGF2alpha, timed artificial insemination (AI), and GnRH-PGF2alpha, relative to AI following estrus detection without hormone intervention. The timed AI protocol involved GnRH, followed by PGF2alpha 7 d later and GnRH again 2 d after PGF2alpha, with AI 6 to 18 h after the second GnRH. The GnRH-PGF2alpha protocol consisted of GnRH followed by PGF2alpha 7 d later. Eight herds relied on visual observation to detect estrus, and eight herds utilized the HeatWatch estrus detection system. The average interval to first postpartum AI was shortest for the timed AI protocol (77.1 d) followed by the 14-d PGF2alpha protocol (81.6 d). There was no difference in days to first AI between the control (86.1 d) and GnRH-PGF2alpha (89.5 d) protocols. Percent pregnant per first AI did not differ among control (45.6%), 14-d PGF2alpha (43.7%), or GnRH-PGF2alpha (44.0%) protocols, but all protocols had a higher percent pregnant per first AI than the timed AI protocol (30.1%). Response to the GnRH-PGF2alpha protocol was limited because 44.0% of the cows submitted to the protocol were not detected in estrus < or = 10 d post-PGF2, administration and had an interval to first AI of 103.8 d. Cumulative percent pregnant by 120 d postpartum did not differ between control cows (53.1%) and hormonally treated cows (50.6%). Visual observation herds had a shorter interval to first postpartum AI (82.8 d) than the HeatWatch herds (84.8 d), with a higher overall rate of estrus detection across all protocols (75.3 and 67.6%, respectively).     

Progesterone supplementation postinsemination improves fertility of cooled dairy cows during the summer

Reduced fertility of dairy cows during periods of elevated temperature, humidity, or both might be associated with low plasma progesterone concentration. Alleviation of thermal stress by efficient cooling is a prerequisite for improving fertility by hormonal treatment. We examined whether insertion of a controlled intravaginal drug-releasing (CIDR) insert containing progesterone following artificial insemination (AI) would improve summer conception rate. Control (n = 195) and treated (CIDR; n=165) cows, yielding on average 42.3 kg milk/d, were inseminated following estrus detection during the summer (July to October) in 2 commercial dairy herds in Israel. Mean maximal air temperature and relative humidity during the study were 30.2°C and 86%, respectively. All experimental cows were efficiently cooled throughout the study, as confirmed by measuring the body temperature of random cows. Treated cows received a CIDR insert on d 5 ± 1 post-AI for 13 d and pregnancy was confirmed by palpation 45 d post-AI. Plasma progesterone concentration in treated cows was elevated by approximately 1.5 ng/mL. Multiple logistic regressions were used to analyze conception rate. Treatment did not alter the overall conception rate; however, probability of conception increased in CIDR-treated cows with low body condition score (BCS) compared with their control counterparts (53 vs. 27%, respectively). A pronounced increase in probability of conception was recorded in CIDR-treated cows exhibiting both low BCS and postpartum reproductive disorders, compared with their control counterparts (58 vs. 14%, respectively). Exogenous progesterone supplementation on d 5 post-AI for 13 d improves summer fertility of subpopulations of cows exhibiting low BCS and postpartum reproductive disorders. Reproductive management based on specific hormonal treatment of designated subgroups of cows known to derive beneficial effects from it might improve treatment efficiency and reduce expenses.     

Mastitis control practices: differences between herds with high and low milk somatic cell counts

Effects of differences in herd mastitis control management in maintaining low herd average SCC, was studied. Washington State DHI herds with Holstein cattle and enrolled in the SCC program (n = 309) were ranked by percentage of cows in their herd with SCC less less than or equal to 283,000 cells/ml. "Low herds" (n = 28) were among the 56 herds with the highest percentage of cows with SCC less than or equal to 283,000 cells/ml and "high herds" (n = 31) were among the 75 with the lowest percentage of cows with SCC less than or equal to 283,000 cells/ml. Herds were visited annually for 2 yr by a technician who collected samples and recorded data. Geometric mean bulk tank SCC during the year between herd visits was 175,000 and 460,000 cells/ml for low and high herds. Milking time hygiene practices, teat dipping, and dry cow therapy were practiced with equal frequency on low and high herds. Differences in function and maintenance of milking equipment did not discriminate between herd groups. Differences in mastitis control management of low versus high SCC herds were that managers of excellent control herds more frequently had highest producers milked first and clinical cows milked last; had automatic milking unit detachers; kept moisture content of cow bedding lower; and had workers disinfect teat ends prior to intramammary antibiotic treatment. Managers of low herds were more likely to use computers and attend dairy informational meetings. Results suggest subtle differences in mastitis control strategies differentiate the low and high SCC herd groups.     

Prostaglandin in milk, days open, and estrus detection in dairy cows treated with prostaglandin F2 alpha

Prostaglandin F2 alpha was used to induce estrus in postpartum dairy cows to decrease calving interval and time spent on heat checks. The amount of prostaglandin residue in milk after treatment also was investigated. Twenty-two control cows, checked for heat twice daily, were bred at estrus after 55 days postpartum. Sixty-three cows checked on days 55 to 60 were either bred if in estrus or treated with 30 mg of prostaglandin F2 alpha injected intramuscularly on day 60 and bred at induced estrus or at 75 h posttreatment. Twelve cows were in heat between days 55 and 60 and were bred. Twenty-nine of 51 treated cows were seen in estrus; all of these were bred and 51.7% conceived at this time. Treated cows had fewer days to first service than did controls, but days open were not different, 105.7 versus 101.8. Fertility was similar. Controls required more heat checks than did treated cows (39 to 8.2). Milk from 17 cows at two milkings before and ten milkings after treatment had similar concentrations of prostaglandin (698 +/- 27 pg/ml) except for the first posttreatment milking when prostaglandin concentration almost doubled (1.293 +/- 143 pg/ml).     

Prevalence and risk factors for postpartum anovulatory condition in dairy cows

The objectives of this research were to determine the prevalence of the anovulatory condition within a temperate region of North America and identify cow-level and herd-level risk factors for this condition. A total of 1,341 cows from 18 herds were classified as cycling or anovular based on skim milk progesterone concentration determined at 46 and 60 ± 7 d in milk. Calving history, periparturient disease incidence, body condition score, milk ketone concentration in the first 2 wk of lactation, and first 305-d mature-equivalent milk projections were recorded. Reproductive and culling information was retrieved monthly from the Dairy Herd Improvement Association. The cow-level prevalence of anovulation was 19.5%, with a herd-specific range from 5 to 45%. Accounting for the effect of clustering at the herd level, cows experiencing a difficult calving, cows with twin calvings, displaced abomasum, and cows with subclinical ketosis in the first week after calving were at greater risk for diagnosis of anovulation. Anovular cows within herds using ovulation synchronization programs were inseminated at the same time postpartum with a 6-percentage point reduction in the probability of pregnancy relative to cycling herdmates (29.7 vs. 35.9%, respectively), whereas anovular cows in herds breeding based on observed estrus were inseminated 8 d later and suffered a 10-percentage point reduction in the probability of pregnancy at first insemination (20.3 vs. 30.5). Time to pregnancy was delayed in anovular cows by 30 d (156 vs. 126 d). Using survival analysis, the impact of anovulation decreased with time. The daily probability of pregnancy (hazard ratio) was similar to cycling cows by 165 d in milk. The results underline the important associations of peripartum health with reproductive function and performance.     

Comparison of timed AI after synchronized ovulation to AI at estrus: reproductive and economic considerations

A timed artificial insemination (TAI) protocol using OvSynch was compared to artificial insemination (AI) at detected estrus in 2 large dairy herds differing in reproductive management. Cows were synchronized for TAI starting at 62 and 42 d in milk in herds 1 and 2, respectively. The OvSynch regimen included: GnRH (buserelin) at 0.02 mg (i.m.) on d 0; PGF2alpha (tiaprost) at 0.75 mg (i.m.) on d 7; buserelin at 0.02 mg (i.m.) on d 9; and TAI 16 to 20 h later. After TAI, cows seen in estrus received AI, whereas cows diagnosed not pregnant were resynchronized for TAI. Control cows received AI based on detected estrus after voluntary waiting periods of 72 d in herd 1 and 50 d in herd 2. An economic analysis included costs associated with days open, culling, AI, synchrony products, treatment, and examinations. A sensitivity analysis of those variables determined effects on total costs per pregnancy. Use of OvSynch reduced intervals to first AI and days open in both herds and reduced culling for infertility in herd 2. Conception rates for first AI at detected estrus were significantly higher compared to TAI in both herds and for overall AI at estrus in herd 2. For groups assigned to AI at estrus, mean 21-d submission rates over 200 d for AI were higher in herd 1 than in herd 2 (55.6 vs. 28.6%). Days open and culling were the major cost factors. Although OvSynch improved reproduction in both herds, AI based on detected estrus was economically superior in herd 1, whereas OvSynch was superior in herd 2. This was consistent across ranges of cost factors evaluated. Evaluation of synchrony protocols should include reproductive performance along with appropriate costs associated with treatments. Such costs may offset benefits to reproduction in herds with good estrous detection rates.     

Synchronization of estrus in dairy heifers: a field demonstration

Use of prostaglandin F2 alpha to synchronize estrus was demonstrated over 3 yr with 2966 dairy heifers in 45 herds. Reproductive status of all heifers was determined before any injections occurred. Anovulatory heifers (8.3%) were not injected or inseminated. Ovulatory heifers received one intramuscular injection and most heifers received two injections of prostaglandin F2 alpha spaced 11 d apart. Observations for estrus and insemination were scheduled and performed by dairy farmers. Insemination of heifers occurred 12 h after detection of estrus or at 80 h after second injection of prostaglandin F2 alpha. Pregnancy rate averaged 50.9% but varied from 0 to 100%. Pregnancy rate after insemination according to estrus (62.8%) was greater than when insemination was at 80 h (39.1%). Low pregnancy rates were associated with limitations in basic management of heifers before or during insemination. Managerial limitations were in timing insemination, range of ages or weights of heifers housed together, number and types of vaccinations, season and diet, frequency of observing heifers for estrus, and number of straws of semen thawed concurrently. Managerial factors that affect fertility are similar whether or not estrus is synchronized. Although agents used to synchronize estrus do not affect fertility directly, managerial limitations on fertility may be accentuated by increased intensity of activity associated with synchronization.     

Comparison of methods for the synchronization of estrous cycles in dairy cows. 1. Effects on plasma progesterone and manifestation of estrus

Dairy cows (n = 571) were treated with 1) one or two injections of prostaglandin F2 alpha given 11 or 14 d apart, 2) two injections given 14 d apart and a progesterone coil inserted 8 d after the first injection for a 7-d period; or 3) a coil inserted for 7 d and prostaglandin injected 1 d before its removal. Cows given two prostaglandin injections that conceived had higher progesterone concentrations during the luteal phase preceding AI than did cows that did not conceive. Cows with progesterone coils that conceived did not have higher progesterone concentrations than did cows that did not conceive. Older cows had lower progesterone concentrations than younger ones, and they appeared in estrus earlier after treatment. In four daily observations, 75% of cows were seen in estrus within 7 d after treatment. Cows mounting two or more times had a conception rate (62%) similar to that of cows that stood to mount. Fewer cows (56%) treated with prostaglandin that had low concentrations of progesterone appeared in estrus than did cows with high progesterone (84%). Cows treated with prostaglandin differ from cows treated with progesterone coils in respect to manifestation of estrus and to the relationship between plasma progesterone and conception.     

Voluntary waiting period and adoption of synchronized breeding in dairy herd improvement herds

Voluntary waiting period and adoption of synchronized breeding (ovulation synchronization followed by timed artificial insemination) were characterized from 33 million services of Holsteins and Jerseys in Dairy Herd Improvement herds. Calving month, calving year, and parity had large effects on days to first service for both breeds. Holstein cows that calved during March and April were bred later than those that calved during other months (February and March for Jerseys), whereas cows that calved during September and October were bred earlier. First-parity cows had longer days to first service than did second-parity cows. Herd-year voluntary waiting period was measured as the days postpartum by which 10% of cows had received a first insemination. Median days to reach 10% of cows bred were 55.5 d. Over 65% of herds had 10% of cows inseminated by 60 d postpartum, the voluntary waiting period assumed for national evaluations for daughter pregnancy rate. Herd-years with synchronized breeding at first insemination were identified through χ² analysis based on deviation of observed frequency of first inseminations by day of the week from an expected equal frequency and by the maximum percentage of cows inseminated on a particular day of the week. Herds that were identified as having synchronized breeding had fewer days to first service (17.0), more services (0.16/cow), and fewer days open (9.1) than did herds that were classified as having traditional estrus detection. Synchronized herds also had a standard deviation for days to first service that was only 38% as large as that for herds that bred on observed estrus. Adoption of synchronized breeding for first services steadily increased from 1.9% of herd-years (2% of cows) for 1996 to 19.9% of herd-years (34.9% of cows) for 2005. Procedures for genetic evaluation of daughter pregnancy rate should be examined to determine if herd regimen for reproductive management affects results.     

Assessing ovulation detection performance in commercial dairy herds using progesterone concentrations from limited numbers of strategically collected milk samples

It is important to assess ovulation detection performance in commercial dairy herds both to investigate low reproductive performance and to enable herd managers to monitor the effectiveness of their system for detecting ovulations. A method was developed to assess ovulation detection performance that uses limited numbers of strategically collected milk samples, assesses performance over the period when herd managers are making maximal effort to detect ovulations, and when assessing proportions of ovulations detected, accounts for false positive diagnoses of estrus and for cows that have not recommenced postpartum ovulatory cycles. Milk was sampled from cows not diagnosed in estrus early in the breeding program (about d 26 in year-round calving herds and d 22 in seasonal calving herds); milk samples were also collected from cows on the day of insemination. Cows with high milk progesterone concentrations were assumed to have had undetected ovulations and false positive diagnoses of estrus, respectively. The method was successfully implemented in 161 of 167 commercial dairy herds. Positive predictive values (PPV; the proportions of ovulation diagnoses where ovulation was, in fact, imminent) were generally high in both year-round and seasonal calving herds (median values were 0.96 and 0.97, respectively), but 25% of herds had PPV <0.95. Ovulation detection sensitivities (ODS) were low in most year-round calving herds, but many seasonal calving herds had high ODS values; median ODS were 0.73 and 0.94, respectively. However, in 25% of seasonal calving herds, ODS was <0.91. These findings indicate that this method for assessing ovulation detection performance can be successfully implemented in commercial dairy herds with appropriate professional support. The wide range of ODS and the absence of correlation between ODS and PPV suggest that it is possible for managers of many commercial herds in Australia to achieve increased reproductive efficiency through increases in ODS and PPV.     

Factors affecting reproductive performance of dairy cows

We conducted two studies to determine how herd management practices and traits of individual cows affect performance of the herd and of the cow within a herd. Management practices, reproductive performance of the herd, and relationships between management and reproductive performance were characterized on 83 dairy farms with 7596 cows. Data included 21 management variables (e.g., facilities, herd health program, estrous detection program) and 8 performance variables obtained from Dairy Herd Improvement or unofficial records (e.g., size of herd, production, days open). Although varying among herds, annual average herd incidences of reproductive disorders and reproductive performance were similar to those reported. Managerial practices influenced incidences of retained placenta and uterine infection, days open of cows not bred and of all cows, services per conception, and percentages of herd open more than 100 days and culled for low production. Veterinarian was the most consistent variable influencing herd reproductive performance. Data also were collected from production and lifetime records of 2532 cows in 19 herds. Reproductive performance was affected by season of calving, production, maturity, and reproductive disorders. Several cows with extremely poor reproductive records were maintained.     

Gonadotropin-releasing hormone and prostaglandin F2 alpha for postpartum dairy cows: estrous, ovulation, and fertility traits

A study of 234 Holstein cows was conducted to determine if early postpartum treatments of gonadotropin-releasing hormone, prostaglandin F2 alpha, or both would alter frequency and occurrence of estrus and ovulation as well as subsequent fertility. Cows in groups 1 and 2 received gonadotropin-releasing hormone (200 micrograms) between 10 and 14 d postpartum, and cows in groups 3 and 4 received saline. Ten days later, cows in groups 2 and 3 received prostaglandin F2 alpha (25 mg), and cows in groups 1 and 4 received saline. Treatment with gonadotropin-releasing hormone reduced intervals to first ovulation and first detected estrus as well as increasing the proportion of cows with three or more ovulations before first service from 57% for saline-treated controls to 83%. Treatment with prostaglandin F2 alpha reduced intervals to second and third ovulation and shortened the first estrous cycle. Treatments for cows in groups 1 and 3 increased the proportion of cows having estrous cycles of normal duration. Interval from calving to conception was reduced by 43 to 48 d for cows with an abnormal puerperium treated with either gonadotropin-releasing hormone or prostaglandin F2 alpha compared with controls (group 4) and by 27 to 29 d overall in all cows in groups 1 and 3. Cows with normal or abnormal puerperium in groups 1 and 3 required 26 to 41% fewer services per conception than controls. We conclude that treatments of gonadotropin releasing hormone or prostaglandin F2 alpha, but not the treatment combination, improved fertility of dairy cows, especially those that experienced puerperal problems.     

Performance of automated activity monitoring systems used in combination with timed artificial insemination compared to timed artificial insemination only in early lactation in dairy cows

Identifying cows in estrus remains a challenge on dairy cattle farms, and tools and technologies have been developed and used to complement or replace visual detection of estrus. Automated activity monitoring (AAM) systems and timed artificial insemination (TAI) are technologies available to dairy farmers, but many factors can influence their relative performance. The objective of the present study was to compare reproductive performance of cows managed with an AAM system combined with TAI, or with a TAI program (Double Ovsynch) for insemination before 88 DIM. From April 2014 to April 2015, 998 cows from 2 herds were randomly assigned either to be inseminated at 85 ± 3 DIM exclusively using the Double Ovsynch protocol for TAI, or to be inseminated based on estrus detection by AAM without hormonal intervention between 50 and 75 DIM; if no alarm was detected by 75 DIM, cows were inseminated following the single Ovsynch protocol (AAM + Ovsynch). The herds used different AAM systems. Parity, hyperketonemia at wk 1 and 2 postpartum (PP), purulent vaginal discharge at wk 5 PP, body condition score at wk 7 PP, and anovulation to wk 9 PP were recorded. These health indicators did not significantly differ between treatments, but did between herds. The effect of treatment on pregnancy at first insemination and by 88 DIM were assessed using logistic regression models. Time to pregnancy was assessed using survival analysis. Results are reported from intention-to-treat analyses. Treatment did not affect pregnancy at first insemination or pregnancy by 88 DIM, but we found significant interactions between treatment and herd for both outcomes. In herd 2, marginal mean pregnancy at first AI was greater with Double Ovsynch (38%) than AAM + Ovsynch (31%), but no difference was observed in herd 1 (Double Ovsynch = 31%; AAM + Ovsynch = 34%). By 88 DIM, a smaller proportion of cows in herd 1 were pregnant in Double Ovsynch (31%) than AAM + Ovsynch (49%), but there was no difference in herd 2 (Double Ovsynch = 38%; AAM + Ovsynch = 38%). We observed a treatment by herd interaction for median (95% confidence interval) time to pregnancy, which were, in herd 1, 110 (106 to 129) and 98 (88 to 113) d, and, in herd 2, 126 (113 to 139) and 116 (105 to 131) d for the Double Ovsynch and AAM + Ovsynch treatments, respectively. The relative performance of AAM-based reproductive management compared with TAI only is likely influenced by herd-specific variables, in particular related to insemination rate when estrus detection is employed.     

Ovarian follicular activity in lactating Holstein cows supplemented with monensin

The objective of this study was to determine effects of monensin on ovarian follicular development and reproductive performance in postpartum dairy cows. Forty-eight multiparous Holstein cows were randomly assigned to receive either a control total mixed ration (n = 24) or the same diet plus 22 mg of monensin/kg (n = 24) from 21 d before anticipated calving until cows were either confirmed pregnant or were >180 d postpartum. Monensin had no effect on development of the first dominant follicle postpartum or the numbers of class 1 (3 to 5 mm), 2 (6 to 9 mm), or 3 (10 to 15 mm) follicles. Control cows had more class 4 (>15 mm) follicles at 10 to 13 d postpartum than cows in the monensin group. The first dominant follicle postpartum ovulated, regressed, or became cystic unrelated to differences between diets. However, the first ovulation postpartum occurred earlier in monensin-fed cows than in the control group (27.2 +/- 2.1 d vs. 32.4 +/- 1.5 d), with no dietary effects on the diameter of the ovulating follicle. Similarly, treatments did not differ in the proportion of cows with 2 or 3 waves of ovarian follicular development per cycle, nor in the number of follicles of all classes during the breeding period. Times of ovulation following treatment with prostaglandin F2alpha were not different between dietary groups. Pregnancy rates after timed artificial insemination were similar between diets. Supplementation with monensin resulted in a shorter postpartum interval to first ovulation but did not affect other reproductive measures in healthy, lactating dairy cows.